| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a6b928fbe43101d5c4203929fcf8d71 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
| filingDate |
2009-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df18156eced02dd436b33cb89505a2dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2bfce06929534e179d7d5cc8288f9bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23b3ce69ab48c6378cba96ea6fcf2377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d83b332decede999ddbdf9bd175b4ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a94bffa2d4e08a53b511db0eccbfffd5 |
| publicationDate |
2010-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2739887-A1 |
| titleOfInvention |
Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate |
| abstract |
The present invention is directed to methods of treating vasomotor symptoms in castrated prostatic cancer patients in need of treatment, comprising administering about 15 mg or less of cyproterone acetate per day to the patients. The present invention is further directed to dosage forms comprising about 1 mg to about 15 mg of cyproterone acetate and a package comprising a plurality of dosage forms comprising about 1 mg to about 15 mg of cyproterone acetate. |
| priorityDate |
2008-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |